WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹887 Cr | ₹617 Cr | ₹-22 Cr | ₹261 Cr | ₹496 Cr |
What is the latest Total Non-Current Liabilities ratio of WOCKHARDT ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹887 Cr |
| Mar2024 | ₹617 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹261 Cr |
| Mar2021 | ₹496 Cr |
How is Total Non-Current Liabilities of WOCKHARDT Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹887 Cr | 43.76 | |
| Mar2024 | ₹617 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹261 Cr | -47.38 | |
| Mar2021 | ₹496 Cr | - | |
Compare Total Non-Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹21,632.8 Cr | -2.5% | -4.9% | 7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,738.0 Cr | 1.4% | 3.5% | -5.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,460.0 Cr | -3.9% | 6.6% | 15.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,476.0 Cr | 7% | 7.8% | 19.8% | Stock Analytics | |
| CIPLA | ₹122,361.0 Cr | 0.8% | 0.2% | -5.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,101.0 Cr | 0.9% | -2.8% | -5.8% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -2.5% |
-4.9% |
7.1% |
| SENSEX | -0.1% |
2.6% |
6.5% |
You may also like the below Video Courses